Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.

Keighley C, Chen SC, Marriott D, Pope A, Chapman B, Kennedy K, Bak N, Underwood N, Wilson HL, McDonald K, Darvall J, Halliday C, Kidd S, Nguyen Q, Hajkowicz K, Sorrell TC, Van Hal S, Slavin MA.

BMC Infect Dis. 2019 May 21;19(1):445. doi: 10.1186/s12879-019-4065-5.

2.

Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types.

Biswas C, Marcelino VR, Van Hal S, Halliday C, Martinez E, Wang Q, Kidd S, Kennedy K, Marriott D, Morrissey CO, Arthur I, Weeks K, Slavin MA, Sorrell TC, Sintchenko V, Meyer W, Chen SC.

Front Microbiol. 2018 Dec 3;9:2946. doi: 10.3389/fmicb.2018.02946. eCollection 2018.

3.

Posaconazole and isavuconazole induced hypomagnesaemia.

Burston J, Robertson M, van Hal S, Pinto AN.

Med Mycol Case Rep. 2018 Sep 28;23:29-30. doi: 10.1016/j.mmcr.2018.09.007. eCollection 2019 Mar. No abstract available.

4.

Identification of multiple species and subpopulations among Australian clinical Sporothrix isolates using whole genome sequencing.

New D, Beukers AG, Kidd SE, Merritt AJ, Weeks K, van Hal SJ, Arthur I.

Med Mycol. 2018 Nov 30. doi: 10.1093/mmy/myy126. [Epub ahead of print]

PMID:
30500920
5.

Invasive Fungal Sinusitis Presenting as Acute Posterior Ischemic Optic Neuropathy.

Ghabrial R, Ananda A, van Hal SJ, Thompson EO, Larsen SR, Heydon P, Gupta R, Cherepanoff S, Rodriguez M, Halmagyi GM.

Neuroophthalmology. 2017 Nov 7;42(4):209-214. doi: 10.1080/01658107.2017.1392581. eCollection 2018 Aug.

6.

Global Scale Dissemination of ST93: A Divergent Staphylococcus aureus Epidemic Lineage That Has Recently Emerged From Remote Northern Australia.

van Hal SJ, Steinig EJ, Andersson P, Holden MTG, Harris SR, Nimmo GR, Williamson DA, Heffernan H, Ritchie SR, Kearns AM, Ellington MJ, Dickson E, de Lencastre H, Coombs GW, Bentley SD, Parkhill J, Holt DC, Giffard PM, Tong SYC.

Front Microbiol. 2018 Jul 9;9:1453. doi: 10.3389/fmicb.2018.01453. eCollection 2018.

7.

Recommendations To Address the Difficulties Encountered When Determining Linezolid Resistance from Whole-Genome Sequencing Data.

Beukers AG, Hasman H, Hegstad K, van Hal SJ.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00613-18. doi: 10.1128/AAC.00613-18. Print 2018 Aug.

8.

Defining the Role of the Environment in the Emergence and Persistence of vanA Vancomycin-Resistant Enterococcus (VRE) in an Intensive Care Unit: A Molecular Epidemiological Study.

Lee AS, White E, Monahan LG, Jensen SO, Chan R, van Hal SJ.

Infect Control Hosp Epidemiol. 2018 Jun;39(6):668-675. doi: 10.1017/ice.2018.29. Epub 2018 Apr 3.

PMID:
29611491
9.

Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.

van Hal SJ, Beukers AG, Timms VJ, Ellem JA, Taylor P, Maley MW, Newton PJ, Ferguson JK, Lee A, Chen SC, Sintchenko V.

J Antimicrob Chemother. 2018 Jun 1;73(6):1487-1491. doi: 10.1093/jac/dky074.

PMID:
29566173
10.

Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia.

Holmes NE, Robinson JO, van Hal SJ, Munckhof WJ, Athan E, Korman TM, Cheng AC, Turnidge JD, Johnson PDR, Howden BP; VANESSA study group, on behalf of the Australasian Society for Infectious Diseases (ASID) Clinical Research Network (CRN).

BMC Infect Dis. 2018 Mar 5;18(1):107. doi: 10.1186/s12879-018-3011-2.

11.

Cronobacter sakazakii Infection from Expressed Breast Milk, Australia.

McMullan R, Menon V, Beukers AG, Jensen SO, van Hal SJ, Davis R.

Emerg Infect Dis. 2018 Feb;24(2):393-394. doi: 10.3201/eid2402.171411.

12.

Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.

Menon V, Davis R, Shackel N, Espedido BA, Beukers AG, Jensen SO, van Hal SJ.

Diagn Microbiol Infect Dis. 2018 Feb;90(2):120-122. doi: 10.1016/j.diagmicrobio.2017.10.017. Epub 2017 Nov 29.

PMID:
29195768
13.

Evaluation of Tobramycin Exposure Predictions in Three Bayesian Forecasting Programmes Compared with Current Clinical Practice in Children and Adults with Cystic Fibrosis.

Burgard M, Sandaradura I, van Hal SJ, Stacey S, Hennig S.

Clin Pharmacokinet. 2018 Aug;57(8):1017-1027. doi: 10.1007/s40262-017-0610-9.

PMID:
29134570
14.

Personalized Medicine and Infectious Disease Management.

Jensen SO, van Hal SJ.

Trends Microbiol. 2017 Nov;25(11):875-876. doi: 10.1016/j.tim.2017.09.006. Epub 2017 Sep 29.

PMID:
28969882
15.

Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.

Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A.

Intensive Care Med. 2017 Oct;43(10):1464-1475. doi: 10.1007/s00134-017-4878-x. Epub 2017 Jul 21. Review.

PMID:
28733718
16.

Acute unilateral peripheral vestibulopathy in neurosyphilis.

Young AS, Carroll AS, Welgampola MS, McCluskey PJ, van Hal SJ, Thompson EO, Burn J, Fulham MJ, Halmagyi GM.

J Neurol Sci. 2017 Jul 15;378:55-58. doi: 10.1016/j.jns.2017.04.038. Epub 2017 Apr 23.

PMID:
28566179
17.

Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis.

Lomax AJ, McGuire HM, McNeil C, Choi CJ, Hersey P, Karikios D, Shannon K, van Hal S, Carr U, Crotty A, Gupta SK, Hollingsworth J, Kim H, Fazekas de St Groth B, McGill N.

Int J Rheum Dis. 2017 Sep;20(9):1277-1285. doi: 10.1111/1756-185X.13076. Epub 2017 May 8.

PMID:
28480561
18.

Changing epidemiology of candidaemia in Australia.

Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, Sorrell TC, van Hal S, Keighley C, Goeman E, Underwood N, Hajkowicz K, Hofmeyr A, Leung M, Macesic N, Botes J, Blyth C, Cooley L, George CR, Kalukottege P, Kesson A, McMullan B, Baird R, Robson J, Korman TM, Pendle S, Weeks K, Liu E, Cheong E, Chen S; Australian and New Zealand Mycoses Interest Group.

J Antimicrob Chemother. 2017 Apr 1;72(4):1103-1108. doi: 10.1093/jac/dkw422. Erratum in: J Antimicrob Chemother. 2017 Apr 1;72 (4):1270.

PMID:
28364558
19.

Inclusions or bystanders? CMV PCR sensitivity and specificity in tissue samples.

Burston J, van Hal S, Dubedat S, Lee A.

J Clin Virol. 2017 May;90:38-39. doi: 10.1016/j.jcv.2017.03.008. Epub 2017 Mar 18. No abstract available.

PMID:
28342315
20.

Establishment of an AUC0-24 Threshold for Nephrotoxicity Is a Step towards Individualized Vancomycin Dosing for Methicillin-Resistant Staphylococcus aureus Bacteremia.

Chavada R, Ghosh N, Sandaradura I, Maley M, Van Hal SJ.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02535-16. doi: 10.1128/AAC.02535-16. Print 2017 May.

21.

Changing epidemiology of candidaemia in Australia.

Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, Sorrell TC, van Hal S, Keighley C, Goeman E, Underwood N, Hajkowicz K, Hofmeyr A, Leung M, Macesic N, Botes J, Blyth C, Cooley L, George CR, Kalukottege P, Kesson A, McMullan B, Baird R, Robson J, Korman TM, Pendle S, Weeks K, Liu E, Cheong E, Chen S; Australian and New Zealand Mycoses Interest Group.

J Antimicrob Chemother. 2017 Apr 1;72(4):1270. doi: 10.1093/jac/dkx047. No abstract available.

PMID:
28204502
22.

Polyclonal emergence of vanA vancomycin-resistant Enterococcus faecium in Australia.

van Hal SJ, Espedido BA, Coombs GW, Howden BP, Korman TM, Nimmo GR, Gosbell IB, Jensen SO.

J Antimicrob Chemother. 2017 Apr 1;72(4):998-1001. doi: 10.1093/jac/dkw539.

PMID:
28031272
23.

MALDI-TOF MS meets WGS in a VRE outbreak investigation.

Schlebusch S, Price GR, Gallagher RL, Horton-Szar V, Elbourne LD, Griffin P, Venter DJ, Jensen SO, Van Hal SJ.

Eur J Clin Microbiol Infect Dis. 2017 Mar;36(3):495-499. doi: 10.1007/s10096-016-2824-4. Epub 2016 Nov 26.

PMID:
27889877
24.

Clinical effectiveness of itraconazole as antifungal prophylaxis in AML patients undergoing intensive chemotherapy in the modern era.

Keighley CL, Manii P, Larsen SR, van Hal S.

Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):213-217. doi: 10.1007/s10096-016-2780-z. Epub 2016 Nov 9.

PMID:
27830376
25.

Evolutionary dynamics of Enterococcus faecium reveals complex genomic relationships between isolates with independent emergence of vancomycin resistance.

van Hal SJ, Ip CLC, Ansari MA, Wilson DJ, Espedido BA, Jensen SO, Bowden R.

Microb Genom. 2016 Jan 19;2(1). doi: 10.1099/mgen.0.000048.

26.

Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations.

Halliday CL, Chen SC, Kidd SE, van Hal S, Chapman B, Heath CH, Lee A, Kennedy KJ, Daveson K, Sorrell TC, Morrissey CO, Marriott DJ, Slavin MA.

Int J Antimicrob Agents. 2016 Oct;48(4):453-8. doi: 10.1016/j.ijantimicag.2016.07.005. Epub 2016 Aug 12.

PMID:
27562696
27.

Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children.

McMullan BJ, Bowen A, Blyth CC, Van Hal S, Korman TM, Buttery J, Voss L, Roberts S, Cooper C, Tong SY, Turnidge J.

JAMA Pediatr. 2016 Oct 1;170(10):979-986. doi: 10.1001/jamapediatrics.2016.1477.

PMID:
27533601
28.

CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.

Tong SY, Nelson J, Paterson DL, Fowler VG Jr, Howden BP, Cheng AC, Chatfield M, Lipman J, Van Hal S, O'Sullivan M, Robinson JO, Yahav D, Lye D, Davis JS; CAMERA2 study group and the Australasian Society for Infectious Diseases Clinical Research Network.

Trials. 2016 Mar 31;17:170. doi: 10.1186/s13063-016-1295-3.

29.

Mucormycosis in Australia: contemporary epidemiology and outcomes.

Kennedy KJ, Daveson K, Slavin MA, van Hal SJ, Sorrell TC, Lee A, Marriott DJ, Chapman B, Halliday CL, Hajkowicz K, Athan E, Bak N, Cheong E, Heath CH, Morrissey CO, Kidd S, Beresford R, Blyth C, Korman TM, Robinson JO, Meyer W, Chen SC; Australia and New Zealand Mycoses Interest Group of the Australasian Society for Infectious Diseases.

Clin Microbiol Infect. 2016 Sep;22(9):775-781. doi: 10.1016/j.cmi.2016.01.005. Epub 2016 Jan 20.

30.

Descriptive epidemiology of infectious gastrointestinal illnesses in Sydney, Australia, 2007-2010.

Fletcher S, Sibbritt D, Stark D, Harkness J, Rawlinson W, Andresen D, Van Hal S, Merif J, Ellis J.

Western Pac Surveill Response J. 2015 Oct 6;6(4):7-16. doi: 10.5365/WPSAR.2015.6.2.006. eCollection 2015 Oct-Dec.

31.

When sepsis persists: a review of MRSA bacteraemia salvage therapy.

Kullar R, Sakoulas G, Deresinski S, van Hal SJ.

J Antimicrob Chemother. 2016 Mar;71(3):576-86. doi: 10.1093/jac/dkv368. Epub 2015 Nov 12. Review.

PMID:
26565015
32.

Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.

Davis JS, Sud A, O'Sullivan MVN, Robinson JO, Ferguson PE, Foo H, van Hal SJ, Ralph AP, Howden BP, Binks PM, Kirby A, Tong SYC; Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA) study group; Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA) study group, Tong S, Davis J, Binks P, Majumdar S, Ralph A, Baird R, Gordon C, Jeremiah C, Leung G, Brischetto A, Crowe A, Dakh F, Whykes K, Kirkwood M, Sud A, Menon M, Somerville L, Subedi S, Owen S, O'Sullivan M, Liu E, Zhou F, Robinson O, Coombs G, Ferguson P, Ralph A, Liu E, Pollet S, Van Hal S, Foo H, Van Hal S, Davis R.

Clin Infect Dis. 2016 Jan 15;62(2):173-180. doi: 10.1093/cid/civ808. Epub 2015 Sep 8.

PMID:
26349552
33.

The use of whole-genome sequencing for molecular epidemiology and antimicrobial surveillance: identifying the role of IncX3 plasmids and the spread of blaNDM-4-like genes in the Enterobacteriaceae.

Espedido BA, Dimitrijovski B, van Hal SJ, Jensen SO.

J Clin Pathol. 2015 Oct;68(10):835-8. doi: 10.1136/jclinpath-2015-203044. Epub 2015 Jun 8.

PMID:
26056157
34.

Whole Genome Sequencing in Real-Time Investigation and Management of a Pseudomonas aeruginosa Outbreak on a Neonatal Intensive Care Unit.

Davis RJ, Jensen SO, Van Hal S, Espedido B, Gordon A, Farhat R, Chan R.

Infect Control Hosp Epidemiol. 2015 Sep;36(9):1058-64. doi: 10.1017/ice.2015.133. Epub 2015 Jun 8.

PMID:
26050101
35.

"Tolerance" of misused terminology? Enforcing standardized phenotypic definitions.

Dimitrijovski B, Jensen SO, Espedido BA, van Hal SJ.

MBio. 2015 Apr 28;6(3):e00446-15. doi: 10.1128/mBio.00446-15. No abstract available.

36.

Convergent adaptation in the dominant global hospital clone ST239 of methicillin-resistant Staphylococcus aureus.

Baines SL, Holt KE, Schultz MB, Seemann T, Howden BO, Jensen SO, van Hal SJ, Coombs GW, Firth N, Powell DR, Stinear TP, Howden BP.

MBio. 2015 Mar 3;6(2):e00080. doi: 10.1128/mBio.00080-15.

37.

Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.

Slavin M, van Hal S, Sorrell TC, Lee A, Marriott DJ, Daveson K, Kennedy K, Hajkowicz K, Halliday C, Athan E, Bak N, Cheong E, Heath CH, Orla Morrissey C, Kidd S, Beresford R, Blyth C, Korman TM, Owen Robinson J, Meyer W, Chen SC; Australia and New Zealand Mycoses Interest Group.

Clin Microbiol Infect. 2015 May;21(5):490.e1-10. doi: 10.1016/j.cmi.2014.12.021. Epub 2015 Jan 14.

38.

Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond.

Holmes NE, Tong SY, Davis JS, van Hal SJ.

Semin Respir Crit Care Med. 2015 Feb;36(1):17-30. doi: 10.1055/s-0034-1397040. Epub 2015 Feb 2. Review.

PMID:
25643268
39.

Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections.

Davis JS, Van Hal S, Tong SY.

Semin Respir Crit Care Med. 2015 Feb;36(1):3-16. doi: 10.1055/s-0034-1396906. Epub 2015 Feb 2. Review.

PMID:
25643267
40.

Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.

Chau MM, Kong DC, van Hal SJ, Urbancic K, Trubiano JA, Cassumbhoy M, Wilkes J, Cooper CM, Roberts JA, Marriott DJ, Worth LJ.

Intern Med J. 2014 Dec;44(12b):1364-88. doi: 10.1111/imj.12600. Review.

PMID:
25482746
41.

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.

Fleming S, Yannakou CK, Haeusler GM, Clark J, Grigg A, Heath CH, Bajel A, van Hal SJ, Chen SC, Milliken ST, Morrissey CO, Tam CS, Szer J, Weinkove R, Slavin MA.

Intern Med J. 2014 Dec;44(12b):1283-97. doi: 10.1111/imj.12595. Review.

PMID:
25482741
42.

Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand.

van Hal SJ, Gilroy NM, Morrissey CO, Worth LJ, Szer J, Tam CS, Chen SC, Thursky KA, Slavin MA.

Intern Med J. 2014 Dec;44(12b):1277-82. doi: 10.1111/imj.12594. Review.

PMID:
25482740
43.

Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia.

Espedido BA, Jensen SO, van Hal SJ.

J Antimicrob Chemother. 2015 Mar;70(3):797-801. doi: 10.1093/jac/dku455. Epub 2014 Nov 17.

PMID:
25406295
44.

Urgent cerebrospinal fluid analysis: is it necessary?

Sivagnanam S, Chan RC, Janto C, Van Hal SJ.

Pathology. 2014 Dec;46(7):649-50. doi: 10.1097/PAT.0000000000000174. No abstract available.

PMID:
25393258
45.

Parvovirus infection: an immunohistochemical study using fetal and placental tissue.

Li JJ, Henwood T, Van Hal S, Charlton A.

Pediatr Dev Pathol. 2015 Jan-Feb;18(1):30-9. doi: 10.2350/14-05-1495-OA.1. Epub 2014 Oct 31.

PMID:
25361230
46.

Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia--authors' response.

Foo H, Chater M, Maley M, van Hal SJ.

J Antimicrob Chemother. 2014 Nov;69(11):3166. doi: 10.1093/jac/dku329. Epub 2014 Aug 12. No abstract available.

PMID:
25118271
47.

Impact of source of infection and vancomycin AUC0-24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Ghosh N, Chavada R, Maley M, van Hal SJ.

Clin Microbiol Infect. 2014 Dec;20(12):O1098-105. doi: 10.1111/1469-0691.12695. Epub 2014 Jul 12.

48.

Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre® YeastOne® for Candida albicans: a prospective observational cohort study.

van Hal SJ, Chen SC, Sorrell TC, Ellis DH, Slavin M, Marriott DM.

J Antimicrob Chemother. 2014 Aug;69(8):2210-4. doi: 10.1093/jac/dku124. Epub 2014 Apr 30.

PMID:
24788656
49.

Reply to "Technical notes on the correct configuration of the Alfred 60/AST device for the detection of urinary tract infections".

Lahanas S, Stathopoulos G, Chan R, van Hal SJ.

J Clin Microbiol. 2014 May;52(5):1807. doi: 10.1128/JCM.00356-14. No abstract available.

50.

Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.

Foo H, Chater M, Maley M, van Hal SJ.

J Antimicrob Chemother. 2014 Aug;69(8):2252-7. doi: 10.1093/jac/dku107. Epub 2014 Apr 16.

PMID:
24744303

Supplemental Content

Loading ...
Support Center